[123I]5-IA-85380 SPECT Imaging of β2-containing Nicotinic Acetylcholine Receptors in Depressed Subjects

Conditions

Bipolar Disorder

What is the purpose of this trial?

This study is looking to determine if depressed nonsmokers and smokers have abnormal regional expression of neuronal β2-containing nicotinic acetylcholine receptor compared to euthymic control patients


Participation Guidelines

Age:
18 Years - 65 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute of Mental Health (NIMH)
Dates:
7/16/2009 - 5/31/2012
Last Updated:
Study HIC#:
0301023934

Clinicaltrials.gov ID: Yale79460871